recombinant mouse plgf2 Search Results


mouse plgf 2  (R&D Systems)
94
R&D Systems mouse plgf 2
Mouse Plgf 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse plgf 2/product/R&D Systems
Average 94 stars, based on 1 article reviews
mouse plgf 2 - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier
recombinant mouse plgf 2  (R&D Systems)
90
R&D Systems recombinant mouse plgf 2
Recombinant Mouse Plgf 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant mouse plgf 2/product/R&D Systems
Average 90 stars, based on 1 article reviews
recombinant mouse plgf 2 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
plgf  (R&D Systems)
94
R&D Systems plgf
Plgf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/plgf/product/R&D Systems
Average 94 stars, based on 1 article reviews
plgf - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier
recombinant plgf mice  (R&D Systems)
93
R&D Systems recombinant plgf mice
Figure 3. TAC stimulates splenic <t>PlGF</t> secretion to induce cardiac RM proliferation and counteract HF (A and B) Serial LV echocardiography in basal condition and 1–2–4–8 weeks after TAC in Cx3cr1/ and WT mice. EF (A) and RWT (B) are shown. n = 4 WT TAC; n = 5 Cx3cr1/ TAC. Data as mean ± SEM and analyzed by two-way ANOVA and Sidak post hoc. ***p < 0.001.
Recombinant Plgf Mice, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant plgf mice/product/R&D Systems
Average 93 stars, based on 1 article reviews
recombinant plgf mice - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier
recombinant mouse plgf 2 protein  (R&D Systems)
N/A
The Recombinant Mouse PlGF 2 Protein from R D Systems is derived from Sf 21 baculovirus The Recombinant Mouse PlGF 2 Protein has been validated for the following applications Binding Activity
   Buy from Supplier
recombinant mouse plgf 2 protein cf  (R&D Systems)
N/A
The Recombinant Mouse PlGF 2 Protein from R D Systems is derived from Sf 21 baculovirus The Recombinant Mouse PlGF 2 Protein has been validated for the following applications Binding Activity
   Buy from Supplier

Image Search Results


Figure 3. TAC stimulates splenic PlGF secretion to induce cardiac RM proliferation and counteract HF (A and B) Serial LV echocardiography in basal condition and 1–2–4–8 weeks after TAC in Cx3cr1/ and WT mice. EF (A) and RWT (B) are shown. n = 4 WT TAC; n = 5 Cx3cr1/ TAC. Data as mean ± SEM and analyzed by two-way ANOVA and Sidak post hoc. ***p < 0.001.

Journal: Immunity

Article Title: A heart-brain-spleen axis controls cardiac remodeling to hypertensive stress.

doi: 10.1016/j.immuni.2025.02.013

Figure Lengend Snippet: Figure 3. TAC stimulates splenic PlGF secretion to induce cardiac RM proliferation and counteract HF (A and B) Serial LV echocardiography in basal condition and 1–2–4–8 weeks after TAC in Cx3cr1/ and WT mice. EF (A) and RWT (B) are shown. n = 4 WT TAC; n = 5 Cx3cr1/ TAC. Data as mean ± SEM and analyzed by two-way ANOVA and Sidak post hoc. ***p < 0.001.

Article Snippet: In vivo administration of recombinant PlGF Mice subjected to splenectomy have been treated by intraperitoneal injection of 1,5 mg/Kg body weight of recombinant PlGF (rPlGF) (R&D Systems) and with NaCl 0.9% as vehicle control as previously described.14 Follow up analysis of cardiac remodeling has been performed by echocardiography.

Techniques:

Figure 4. Splenic-derived PlGF promotes the expansion of RMs and hinders HF (A and B) Immunofluorescence (A) and quantification (B) of PlGF in the splenic marginal zone delimited by ERTR7+ fibroblast reticular cells in sham or TAC mice subjected to CGX or control (scale bar, 50 mm). n = 6 sham; n = 5 TAC; n = 5 TAC CGX. Data as mean ± SEM and analyzed by one-way ANOVA and Tukey post hoc. *p < 0.05. (legend continued on next page)

Journal: Immunity

Article Title: A heart-brain-spleen axis controls cardiac remodeling to hypertensive stress.

doi: 10.1016/j.immuni.2025.02.013

Figure Lengend Snippet: Figure 4. Splenic-derived PlGF promotes the expansion of RMs and hinders HF (A and B) Immunofluorescence (A) and quantification (B) of PlGF in the splenic marginal zone delimited by ERTR7+ fibroblast reticular cells in sham or TAC mice subjected to CGX or control (scale bar, 50 mm). n = 6 sham; n = 5 TAC; n = 5 TAC CGX. Data as mean ± SEM and analyzed by one-way ANOVA and Tukey post hoc. *p < 0.05. (legend continued on next page)

Article Snippet: In vivo administration of recombinant PlGF Mice subjected to splenectomy have been treated by intraperitoneal injection of 1,5 mg/Kg body weight of recombinant PlGF (rPlGF) (R&D Systems) and with NaCl 0.9% as vehicle control as previously described.14 Follow up analysis of cardiac remodeling has been performed by echocardiography.

Techniques: Derivative Assay, Control

Figure 6. PlGF-NRP1 mediates adaptive functions of macrophages during pressure overload (A and B) Flow cytometry (A) and quantification (B) of NRP1 expression in cardiac Ly6CloTimd4Lyve-1+ RMs after TAC. n = 6 sham; n = 7 TAC. Data as mean ± SEM and analyzed by unpaired t test. ***p < 0.001.

Journal: Immunity

Article Title: A heart-brain-spleen axis controls cardiac remodeling to hypertensive stress.

doi: 10.1016/j.immuni.2025.02.013

Figure Lengend Snippet: Figure 6. PlGF-NRP1 mediates adaptive functions of macrophages during pressure overload (A and B) Flow cytometry (A) and quantification (B) of NRP1 expression in cardiac Ly6CloTimd4Lyve-1+ RMs after TAC. n = 6 sham; n = 7 TAC. Data as mean ± SEM and analyzed by unpaired t test. ***p < 0.001.

Article Snippet: In vivo administration of recombinant PlGF Mice subjected to splenectomy have been treated by intraperitoneal injection of 1,5 mg/Kg body weight of recombinant PlGF (rPlGF) (R&D Systems) and with NaCl 0.9% as vehicle control as previously described.14 Follow up analysis of cardiac remodeling has been performed by echocardiography.

Techniques: Flow Cytometry, Expressing